简介：AbstractBackground:The cancer burden in the United States of America (USA) has decreased gradually. However, China is experiencing a transition in its cancer profiles, with greater incidence of cancers that were previously more common in the USA. This study compared the latest cancer profiles, trends, and determinants between China and USA.Methods:This was a comparative study using open-source data. Cancer cases and deaths in 2022 were calculated using cancer estimates from GLOBOCAN 2020 and population estimates from the United Nations. Trends in cancer incidence and mortality rates in the USA used data from the Surveillance, Epidemiology, and End Results program and National Center for Health Statistics. Chinese data were obtained from cancer registry reports. Data from the Global Burden of Disease 2019 and a decomposition method were used to express cancer deaths as the product of four determinant factors.Results:In 2022, there will be approximately 4,820,000 and 2,370,000 new cancer cases, and 3,210,000 and 640,000 cancer deaths in China and the USA, respectively. The most common cancers are lung cancer in China and breast cancer in the USA, and lung cancer is the leading cause of cancer death in both. Age-standardized incidence and mortality rates for lung cancer and colorectal cancer in the USA have decreased significantly recently, but rates of liver cancer have increased slightly. Rates of stomach, liver, and esophageal cancer decreased gradually in China, but rates have increased for colorectal cancer in the whole population, prostate cancer in men, and other seven cancer types in women. Increases in adult population size and population aging were major determinants for incremental cancer deaths, and case-fatality rates contributed to reduced cancer deaths in both countries.Conclusions:The decreasing cancer burden in liver, stomach, and esophagus, and increasing burden in lung, colorectum, breast, and prostate, mean that cancer profiles in China and the USA are converging. Population aging is a growing determinant of incremental cancer burden. Progress in cancer prevention and care in the USA, and measures to actively respond to population aging, may help China to reduce the cancer burden.

简介：

简介：

简介：

简介：

简介：AbstractObjective:Nasopharyngeal cancer (NPC) has distinct characteristics regarding its global prevalence, initial presentation, management and patient outcomes compared to other subtypes of head and neck cancer (HNC). The mainstay of NPC treatment is chemo-radiation (C/RT) and while dysphagia is a known early and late toxicity of C/RT treatment, the nature of dysphagia post NPC treatment has had limited investigation. The objective of this review is to summarise the existing evidence regarding dysphagia following NPC to inform the future research agenda for this population. Dysphagia incidence, characteristic deficits observed across the phases of swallowing, efficacy of current dysphagia interventions, and effect on quality of life will be explored.Data sources:Databases including MEDLINE, CINAHL, Embase, Scopus and Web of Science were included.Methods:A scoping review was conducted according to PRISMA-ScR guidelines. Two independent reviewers screened selected full text articles.Results:Of the initial 2495 articles found, 28 articles were included. Reports of penetration and aspiration varied widely (0%-91.6%), with high rates of silent aspiration identified in 2 studies (42%, 66%). Oral, pharyngeal and upper esophageal phase impairments were reported. Of these, upper esophageal stasis and multiple pharyngeal stage deficits were most prevalent. The pharyngeal constrictors were found to have a significant dose-effect relationship and shielding to the anterior neck field was effective to preserve swallowing function. Six treatment studies were identified with limited evidence supporting the use of neuromuscular electrical stimulation, dilatation and swallowing exercises. Quality of life was adversely affected.Conclusions:Dysphagia is a prevalent early and late problem post NPC treatment, with impairments across all phases of the swallow. Studies on preventing dysphagia and treatment efficacy remain limited. More systematic study of the nature of dysphagia and the efficacy of treatment in this population is warranted.

简介：无

简介：对为前列腺癌症的更有效的治疗学的途径有批评需要。然而，在这个区域的研究被缺乏严重妨碍了临床上相关，在疾病的vivo模型试验性。这评论特别地基于patients’的subrenal囊grafting集中于前列腺癌症异种皮移植模型的发展；进nonobese糖尿病/严重的肿瘤组织联合了immunodeficient(NOD/SCID)老鼠。这种技术允许可移植的、导出病人的癌症织物异种皮移植线的成功的开发从不仅好攻击变形，而且从局部性的前列腺癌症纸巾。异种皮移植被发现了保留原来的恶意的关键生物性质，包括组织病理学说、分子的特征，肿瘤异质，对雄激素脱离的反应和变形能力。因此，他们是高度临床上相关并且在细胞、分子的层次，为个性化的癌症治疗屏蔽的药和现出症状之前的潜的药为前列腺癌症前进的研究提供珍贵工具测试的功效；特别当模型的一块面板习惯于盖子时许多疾病。这些异种皮移植模型能因此被看作前列腺癌症的下一代的模型。

简介：Objective:LivercancerisoneofthemostcommoncancersandmajorcauseofcancerdeathsinChina,whichaccountsforover50%ofnewcasesanddeathsworldwide.Thesystematiclivercancerstatisticsincludingofprojectionthrough2030couldprovidevaluableinformationforpreventionandcontrolstrategiesinChina,andexperienceforothercountries.Methods:TheburdenoflivercancerinChinain2014wasestimatedusing339cancerregistries’dataselectedfromChineseNationalCancerCenter(NCC).Incidentcasesof22cancerregistrieswereappliedfortemporaltrendsfrom2000to2014.Theburdenoflivercancerthrough2030wasprojectedusingage-period-cohortmodel.Results:About364,800newcasesoflivercancer(268,900malesand95,900females)occurredinChina,andabout318,800livercancerdeaths(233,500malesand85,300females)in2014.WesternregionsofChinahadthehighestincidenceandmortalityrates.Incidenceandmortalityratesdecreasedbyabout2.3%and2.6%peryearduringtheperiodof2000-2014,respectively,andwoulddecreasebymorethan44%between2014and2030inChina.Theyounggeneration,particularlyforthoseagedunder40years,showedafasterdowntrend.Conclusions:Basedontheanalysis,incidenceandmortalityratesoflivercancerareexpectedtodecreasethrough2030,buttheburdenoflivercancerisstillseriousinChina,especiallyinruralandwesternareas.MostcasesoflivercancerinChinacanbepreventedthroughvaccinationandmorepreventioneffortsshouldbefocusedonhighriskgroups.

简介：Breastcancerisoneofthemostcommonlydiagnosedmalignanciesandtheleadingcauseofcancerdeathofwomenovertheworld.AlargenumberoffemaleswithbreastcancerinVietnamandotherSoutheastAsian(SEA)countriespresentatanearlyagewithmoreaggressivetumorscomparedwithwomeninAustralia.Despiteexperiencingalowincidencerate,theincreasingincidencerateamongSEAcountriesexceedsthatoftheWesternizedworld.Changesinreproductivefactors,environmentalexposures,andlifestylearethepossiblecausesofthistrend.However,limitedevidenceshowsthatthesefactorsareassociatedwithbreastcancerintheVietnamesepopulation.BreastcancerincidencerateswithinVietnamarenotuniformandappeartobedependentongeographiclocation.FindingsfromthisreviewhaveimportantimplicationsforbreastcancercontrolandtreatmentinVietnam.AgoodunderstandingofthemorphologyofthebreastandthetypeandnatureofbreastcancerspresentinginVietnamisrequiredtofacilitatetheintroductionofaneffectivenationalbreastscreeningprogram.

简介：AIM:Toconductasystematicreviewofthepublishedepidemiologicalstudiesinvestigatingtheassociationoftheinteractionsbetweengenevariantsanddietaryintakewithgastriccancerrisk.METHODS:AliteraturesearchwasconductedinPubMed,EMBASE,andMEDLINEforarticlespublishedbetweenJanuary2000andJuly2013,and38studieswereidentified.Previousstudiesincludedvariousdietaryfactors(e.g.,fruitsandvegetables,soybeanproducts,salt,meat,andalcohol)andgeneticvariantsthatareinvolvedinvariousmetabolicpathways.RESULTS:Studiessuggestthatindividualswhocarryhigh-riskgeneticvariantsanddemonstrateparticulardietaryhabitsmayhaveanincreasedriskofgastriccancercomparedwiththosewhodonotcarryhigh-riskgeneticvariants.Distinctivedietarypatternsandvariationsinthefrequencyofgeneticvariantsmayexplainthehigherincidenceofgastriccancerinaparticularregion.However,mostpreviousstudieshavelimitations,suchasasmallsamplesizeandaretrospectivecasecontroldesign.Inaddition,paststudieshavebeenunabletoelucidatethespecificmechanismingene-dietinteractionassociatedwithgastriccarcinogenesis.CONCLUSION:Additionallargeprospectiveepidemiologicalandexperimentalstudiesarerequiredtoidentifythegene-dietmetabolicpathwaysrelatedtogastriccancersusceptibility.

简介：Objective:Survivalandtreatmentofpatientswithmicroinvasivebreastcancer(MIBC)remaincontroversial.Inthispaper,weevaluatedwhetheradjuvantchemotherapyisnecessaryforpatientswithMIBCtoidentifyriskfactorsinfluencingitsprognosisanddecidetheindicationforadjuvantchemotherapy.Methods:Inthisretrospectivestudy,108patientswithMIBCwererecruitedaccordingtoseventheditionofthestagingmanualoftheAmericanJointCommitteeonCancer(AJCC).Thesubjectsweredividedintochemotherapyandnon-chemotherapygroups.Wecomparedthe5-yeardisease-freesurvival(DFS)andoverallsurvival(OS)ratesbetweengroups.Furthermore,weanalyzedthefactorsrelatedtoprognosisforpatientswithMIBCusingunivariateandmultivariateanalyses.Wealsoevaluatedtheimpactofadjuvantchemotherapyontheprognosticfactorsbysubgroupanalysisaftermedianfollow-uptimeof33months(13-104months).Results:The5-yearDFSandOSratesforthechemotherapygroupwere93.7%and97.5%,whereasthoseforthenonchemotherapygroupwere89.7%and100%.Resultsindicatethat5-yearDFSwassuperior,butOSwasinferior,intheformergroupcomparedwiththelattergroup.However,nostatisticalsignificancewasobservedinthe5-yearDFS(P=0.223)orOS(P=0.530)rateofthetwogroups.Mostrelevantpoor-prognosticfactorswereKi-67overexpressionandnegativehormonalreceptors.Cumulativesurvivalwas98.2%vs.86.5%betweenlowKi-67(≤20%)andhighKi-67(>20%).ThehazardratioofpatientswithhighKi-67was16.585[95%confidenceinterval(CI),1.969-139.724;P=0.010].Meanwhile,ER(-)/PR(-)patientswithMIBChadcumulativesurvivalof79.3%comparedwith97.5%forER(+)orPR(+)patientswithMIBC.ThehazardratioforER(-)/PR(-)patientswithMIBCwas19.149(95%CI,3.702-99.057;P<0.001).SubgroupanalysisshowedthatchemotherapycouldimprovetheoutcomesofER(-)/PR(-)patients(P=0.014),butnotthosewhooverexpressKi-67(P=0.105).Conclusions:PatientswithMIBCwhooverexpressKi-67and

简介：观察联系adeno的病毒的向量(AAV)的生长抑制效果的目的调停了在老鼠和它的机制的植入的乳癌上的angiostatin(ANG)基因。方法基因转移技术被用来把AAV-ANG转移到肿瘤。生长曲线被拉观察在老鼠，和免疫植入的乳癌的生长组织化学的方法被用来在在老鼠植入的乳癌的microvesel密度(MVD)上检测angiostatin的效果。结果Angiostatin禁止了在老鼠植入并且减少的乳癌的生长肿瘤的微容器密度。angiostatintransgene的结论表示能压制通过微容器的生长的抑制在老鼠植入的乳癌的生长，angiostatin基因转移技术可能对乳癌是有效的surggesting。

简介：AbstractBackground:According to the Independent High-level Commission on Non-communicable Diseases (NCD) of the World Health Organization (WHO), global reduction in lung cancer mortality has been achieved since the year 2000, although this effect is not sufficient to reach the 30% reduction of mortality from NCDs by the year 2030, as stipulated by the United Nations Sustainable Development Goal 3.4. The objective of this study was to analyze whether the lifestyle changes implemented by the WHO at country level could have an impact on mortality from this form of cancer.Methods:WHO statistics, based on the unified mortality and causes-of-death reports of Member-State countries, were used to evaluate global lung cancer mortality trends and make comparisons and assessments of different types of community-based, country-wide interventions.Results:The lung cancer mortality decline was associated with the anti-tobacco campaign initiated by the WHO in the last 15 to 20 years. Comprehensive tobacco control remained the major and most successful lifestyle modification measure. In countries with declining lung cancer mortality, 91% of countries had decreasing tobacco prevalence in males and 82% in females. Country-wide measures to increase physical activity had a strong tendency to be better implemented in countries with declining lung cancer mortality (t = 1.79, P > 0.05). Other WHO "best-buy" lifestyle modification campaigns (diet and alcohol) had been carried out for shorter periods, and their associations with lung cancer were less strong than tobacco. There was no significant difference between countries with declining and increasing lung cancer mortality in the measures for reduction of harmful alcohol use (t= 0.92, P > 0.05) and unhealthy diet reduction measures (t= 0.84, P > 0.05).Conclusion:Following WHO "best-buys" should facilitate to move countries towards the NCD including lung cancer mortality reduction targets. Governments and communities must embrace these targets with coordinated effective action for better health.

简介：观察aerosolized组A的吸入的功效的目的链状球菌(气体)在在老鼠治疗orthotopic肺癌症的准备当模特儿并且为肺癌症估计这个管理模式的可行性，安全，和有效性。方法路易斯肺癌(LLC)房间紧张经由intrathoracic注射被管理建立orthotopic肺癌症老鼠模型。在忍受肿瘤的模型成功地被建立，由计算断层摄影术证实了以后，老鼠被吸入与aerosolized气体准备(煤气的组)或aerosolized正常管理盐(控制组)。aerosolized气体准备的反肿瘤效果组织学地被评估；同时，生活的幸存和质量在这二个组之间被比较。aerosolized气体准备显著地显示出的结果反肿瘤效果，在忍受肿瘤的老鼠引起orthotopic肺癌症房间的坏死。而且，在煤气的组的鼠标在控制组比那些有生活和更长的幸存的显著地更好的质量。aerosolized气体准备的吸入可以是肺癌症的一个可行、安全、有效的解决方案的结论。

简介：Objective:Toinvestigatetheprevalenceoflong-termfatigue,anxiety,depressionandsocialsupport,andtherelationshipsamongthesesymptomsinpostoperativepatientswithbreastcancer.Methods:Atotalof180postoperativepatientswithbreastcancermeetingcriterionwererecruitedinthiscross-sectionalstudy.TheBriefFatigueInventory(BFI),HospitalAnxietyandDepressionScale(HADS)andTheSocialSupportSurvey-Chineseversionwereusedtoassessingthefatigue,anxietyanddepression,Socialsupportofparticipants.ThemagnitudeoftherelationshipamongthesymptomsoffatigueandothervariableswasmeasuredbySpearmanRhocorrelation.Results:Theprevalenceoflong-termfatiguewas52.7%,and18.3%occurredmoderate/severefatigue.Two-thirdsofpatientshadabasalsocialsupport,only12.8%ofpatientshadbetter-perceivedsocialsupport.ResultsofHADSshowedthat16.7%and21.1%oftheparticipantshaveanxietyordepressiondisorder.Moderate/severefatiguewasnegativelycorrelatedwithsocialsupport(r=–0.158,P=0.038)andpositivelycorrelatedwithage(r=0.132,P=0.042),chemotherapy(r=0.297,P=0.027),anxiety(r=0.324,P=0.018)anddepression(r=0.211,P=0.034).Conclusions:Long-termfatiguewashighlyprevalentamongoverhalfofpostoperativepatientswithbreastcancer,andmoderate/severefatiguewasassociatedwithsocialandpsychologicalfactorssuchassocialsupport,anxietyanddepression.Ourresultssuggestthatoverallnursingcaremaybeamoreeffectivemannerinimprovingfatigueandqualityoflife.

简介：Epithelialovariancancer(EOC)istheleadingcauseofdeathamongallgynecologicalmalignancies.Despitethetechnologicalandmedicaladvancesoverthepastfourdecades,suchasthedevelopmentofseveralbiologicalmarkers(mRNAandproteinsbiomarkers),themortalityrateofovariancancerremainsachallengebecauseofitslatediagnosis,whichisspecificallyattributedtolowspecificitiesandsensitivities.Underthiscompulsivescenario,recentadvancesinexpressionbiologyhaveshiftedinidentifyinganddevelopingspecificandsensitivebiomarkers,suchasmicroRNAs(miRNAs)forcancerdiagnosisandprognosis.MiRNAsareanovelclassofsmallnon-codingRNAsthatderegulategeneexpressionattheposttranscriptionallevel,eitherbytranslationalrepressionorbymRNAdegradation.Thesemechanismsmaybeinvolvedinacomplexcascadeofcellulareventsassociatedwiththepathophysiologyofmanytypesofcancer.MiRNAsareeasilydetectableintissueandbloodsamplesofcancerpatients.Therefore,miRNAsholdgoodpromiseaspotentialbiomarkersinovariancancer.Inthisreview,weattemptedtoprovideacomprehensiveprofileofkeymiRNAsinvolvedinovariancarcinomatoestablishmiRNAsasmorereliablenon-invasiveclinicalbiomarkersforearlydetectionofovariancancercomparedwithproteinandDNAbiomarkers.

简介：Radiationtherapyperformsanimportantfunctionincancertreatment.However,resistanceoftumorcellstoradiationtherapystillremainsaseriousconcern,sothestudyofradiosensitizershasemergedasapersistenthotspotinradiationoncology.Alongwiththerapidadvancementofnanotechnologyinrecentyears,thepotentialvalueofnanoparticlesasnovelradiosensitizershasbeendiscovered.Thisreviewsummarizesthelatestexperimentalfindingsbothinvitroandinvivoandattemptstohighlighttheunderlyingmechanismsofresponseinnanoparticleradiosensitization.

简介：EpidemiologicalstudiesshowedtheincidencemortalityratesofcancerwereincreasinginrecentdecadesinChinesepopulation.Nationalandregionalpreventiveprogramsaimtoreducethehealthhazardsofcancerandfocusethepopulationathighrisksforspecificcancer,particularlyinruralareasandtooffertheaccesstoearlydetectionformultlplecancersinurbanareas.Theearlyscreening,earlydetectionandtreatmenthavebeenputintooperationforthepopulationatrisksinruralareasatfirst,andintheurbanareasinrecentyears.Tounderstandtheepidemicpatternsandtrendsofcancer,andtheexperiencesinapplyingearlydetectionstrategiesinChina,selectedliteratureswerereviewedforbriefsummary.

简介：组织缺氧可诱导的factor-1α；(HIF-1α；)在调整angiogenesis起一个重要作用，它为肿瘤生长和转移是必要的。HIF1A的基因变化(编码HIF-1α；)被显示了影响一个个人的危险性到许多人的肿瘤；然而，在在HIF1A单个核苷酸的多型性(SNP)和风险正在冲突的前列腺癌症(PCa)之间的协会上证实。我们genotyped在用TaqMan方法的HIF1A(rs11549465，rs11549467和rs2057482)的三潜在地功能的多型性并且在662 的盒子控制研究与PCa风险估计了他们的协会；在一张中国汉人口的PCa病人和716控制。与rs11549467GG遗传型相比，变体遗传型GA+；AA有显著地增加的PCa风险(调整机会比率(或)=1.70；95%；信心间隔(CI)=1.06-2.72)，特别地在更老的病人之中(OR=2.01；95%；CI=1.05-3.86)，吸烟者(OR=2.06；95%；CI=1.07-3.99)，从未喝酒者(OR=2.16；95%；CI=1.20-3.86)并且没有癌症的家庭历史的病人(OR=1.71；95%；CI=1.02-2.89)。而且，有rs11549467变体遗传型的病人与一个更高级的格利森分数被联系(OR=2.14；95%；CI=1.22-3.75)。没有改变的PCa风险与rs11549465和rs2057482多型性被联系。然而，rs2057482和rs11549467的联合变体遗传型与增加的PCa风险被联系(OR=2.10；95%；在带三的题目或更多的风险等位基因之中的CI=1.23-3.57)。这些结果建议HIF1A多型性可以在中国汉人口影响PCa危险性和前进。